Delivery Order SPE2DB22D1017-SPE2DB24FF5DU
- Not listed
- The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract valued at $4,700.16 to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,565,681,900 units of the prescription drug Tivicay 50 mg Tablet 30s. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of pharmaceutical and...
- The U.S. Defense Logistics Agency (DLA) awarded a $13,159.40 delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 4,565,295,968 units of the HIV medication Tivicay 50 mg tablets. The contract has a firm fixed price and an ultimate completion date of July 31, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $17,051.31 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to supply TIVICAY 50 MG TABLET 30S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,671.25, is for the delivery of 4,567,984,596 units of the prescription medication Tivicay 50 mg tablet. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 22, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TIVICAY 50 MG TABLET 30S. The contract has a ceiling value of $1,248.07 and a period of performance through March 18, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tivicay 50 mg tablets (30-count units) under a firm fixed-price contract structure. The award, issued on June 17, 2025, carries a ceiling value of $6,361.40 and requires completion by June 18, 2025. AmerisourceBergen will perform this work from its corporate office in Conshohocken, Pennsylvania. This is a non-set-aside award issued through open competition, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30 tablets of Tivicay 50 mg with a ceiling value of $1,334.31 under a firm fixed price contract type. This award, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation, and performance...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Tivicay 50 mg tablets. The award has a ceiling value of $24,608.78 and a completion date of April 26, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen Drug Corp is the prime contractor for this award, which is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999...
- The Defense Logistics Agency awarded a delivery order valued at $2,277.11 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Tivicay 50 mg tablets (30-count units). This is a firm fixed price delivery order with no set-aside designation, representing a competitive award under the company's existing contract vehicle. Performance will occur at the awardee's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. This...
- This federal contract award, valued at $19,711.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tivicay 50 mg tablets, a prescription medication, to support military healthcare programs. The contract is a Delivery Order under an existing Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF5DUDelivery Order
The Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, through its Corporate Office division, to provide Tivicay 50 mg tablets. The contract has a ceiling value of $1,585.98 and a period of performance through April 2, 2024. This award is a task order placed under an existing indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and runs through December 31, 2025. The IDC serves as the primary vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 4/1/24 |